Revvity (RVTY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Mar, 2026Executive summary
Annual meeting scheduled for April 28, 2026, with voting available online and virtually.
Shareholders are encouraged to review proxy materials and vote on key proposals by specified deadlines.
Voting matters and shareholder proposals
Election of ten director nominees for one-year terms is up for vote.
Ratification of Deloitte & Touche LLP as independent auditor for the current fiscal year.
Advisory vote on executive compensation (say-on-pay) is included.
Proposal to amend by-laws to allow shareholders with 25% ownership to call a special meeting.
Shareholder proposal requiring executives to retain significant stock is presented, with board recommending against.
Board of directors and corporate governance
Ten nominees for director positions are listed, each recommended for election for a one-year term.
Board recommends voting for all director nominees.
Latest events from Revvity
- Divestiture of China immunodiagnostics boosts growth outlook; AI and software launches drive optimism.RVTY
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue up 7%, strong organic growth, and China divestiture shapes 2026 outlook.RVTY
Q1 202612 May 2026 - Board elections, auditor ratification, and bylaw changes passed; stock retention proposal failed.RVTY
AGM 202628 Apr 2026 - Board recommends all management proposals, including by-law amendment, and opposes stock retention proposal.RVTY
Proxy Filing16 Mar 2026 - AI-powered Signals launches and new revenue models drive growth amid cautious market outlook.RVTY
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Board recommends all management proposals, opposes executive stock retention proposal.RVTY
Proxy Filing6 Mar 2026 - Cost actions and innovation drive margin expansion and growth across diagnostics and software.RVTY
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Innovation and operational excellence drive growth, with AI and margin expansion as key themes.RVTY
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Q2 revenue fell 2% but adjusted EPS rose and buybacks will accelerate.RVTY
Q2 20242 Feb 2026